The Ministry of Public Health (MoPH) is working on developing and implementing a national medication safety programme.
This is done in cooperation with the WHO Office in Qatar and the Regional Office for the Eastern Mediterranean, with the participation of all stakeholders from the health and academic sectors in addition to the pharmaceutical manufacturing sector as well as patient representatives.
The initiative aims to develop a national plan for a medication safety programme, which is one of the important projects within the second national health strategy 201-8-2022, and the third national health strategy. It also aims to identify priorities and gaps with regard to medication safety systems and practices in line with the "Medication Without Harm" challenge launched by the WHO in 2017, one of the global challenges launched by WHO for patient safety.